UK'S MHRA: TARLATAMAB APPROVED TO TREAT ADULT PATIENTS WITH SMALL CELL LUNG CANCER
Further company coverage: AMGN.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.